2008 - 12 Noon - 1:00pm
"Advances in Lung Cancer Therapy"
Dr. Wakelee is a Stanford University Assistant Professor of
Medicine, Oncology and clinical investigator. Dr. Wakelee is the program leader
for the clinical lung cancer program at StanfordAngiogenesis
is the formation of new blood vessels from existing ones and is an important
process in cancer growth).
and is running a variety of clinical trials with novel therapies for lung cancer
patients. Her current focus is on antiangiogenesis strategies.
Dr. Wakelee has also done research in chemotherapy for patients
with brain metastases from lung cancer, as well as with chemotherapy for newly
diagnosed lung cancer patients.
Dr. Wakelee will be speaking on lung cancer causes and treatments including how
the disease differs in smokers versus nonsmokers, women versus men, and in older
versus younger patients.
Wednesday, January 23,
12 Noon - 1:00
SLAC, 2575 Sand Hill Rd., Menlo
Everyone is welcome - bring
your lunch & a friend!